Obstructive airway diseases: what the agencies decided
11 molecules in ATC class R03 with a published cross-agency decision record.
| Molecule | Decisions | Agencies | Class |
|---|---|---|---|
| mepolizumab | 59 | 15 | Obstructive airway diseases |
| omalizumab | 43 | 12 | Obstructive airway diseases |
| benralizumab | 31 | 15 | Obstructive airway diseases |
| tezepelumab | 24 | 13 | Obstructive airway diseases |
| budesonide / formoterol | 22 | 4 | Obstructive airway diseases |
| glycopyrronium | 22 | 8 | Obstructive airway diseases |
| salbutamol | 15 | 6 | Obstructive airway diseases |
| montelukast | 13 | 4 | Obstructive airway diseases |
| depemokimab | 8 | 7 | Obstructive airway diseases |
| indacaterol | 8 | 6 | Obstructive airway diseases |
| roflumilast | 7 | 5 | Obstructive airway diseases |